Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study
J Antimicrob Chemother
.
2018 Jun 1;73(6):1733-1734.
doi: 10.1093/jac/dkx497.
Authors
Tom Decroo
1
,
Armand Van Deun
2
3
,
Lutgarde Lynen
1
Affiliations
1
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
2
Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
3
International Union Against Tuberculosis and Lung Disease, Paris, France.
PMID:
29293989
DOI:
10.1093/jac/dkx497
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents
HIV Infections*
Humans
Isoniazid*
Prospective Studies
Treatment Outcome
Substances
Antitubercular Agents
Isoniazid